In vivo volumetric intravascular ultrasound visualization of early/inflammatory arterial atheroma using targeted echogenic immunoliposomes

Investigative Radiology

Volumn 45, Issue 10, 2010, Pages 685-691

  Kim, Hyunggun ^a   Moody, Melanie R ^a   Laing, Susan T ^a   Kee, Patrick H ^a   Huang, Shao Ling ^a   Klegerman, Melvin E ^a   McPherson, David D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

3D reconstruction; atherosclerosis; intravascular ultrasound; liposomes; targeted

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOLIPOSOME; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; MONOCLONAL ANTIBODY; TARGETED ECHOGENIC IMMUNOLIPOSOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE COURSE; ELECTROCARDIOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INTRAVASCULAR ULTRASOUND; MINIPIG; MOLECULAR IMAGING; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING;

EID: 77957287357     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181ee5bdd     Document Type: Article

References (34)

1. McPherson DD, Sirna SJ, Hiratzka LF, et al. Coronary arterial remodeling studied by high-frequency epicardial echocardiography: an early compensatory mechanism in patients with obstructive coronary atherosclerosis. J Am Coll Cardiol. 1991;17:79-86.
2. Kitney RI, Moura L, Straughan K. 3-D visualization of arterial structures using ultrasound and Voxel modelling. Int J Card Imaging. 1989;4:135-143.
3. Lee RT, Richardson SG, Loree HM, et al. Prediction of mechanical properties of human atherosclerotic tissue by high-frequency intravascular ultrasound imaging: an in vitro study. Arterioscler Thromb. 1992;12:1-5.
4. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
5. Ross R. Atherosclerosis\an inflammatory disease. N Engl J Med. 1999;340: 115-126.
6. Huo Y, Ley K. Adhesion molecules and atherogenesis. Acta Physiol Scand. 2001;173:35-43.
7. Kasper HU, Schmidt A, Roessner A. Expression of the adhesion molecules ICAM, VCAM, and ELAM in the arteriosclerotic plaque. Gen Diagn Pathol. 1996;141:289-294.
8. Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology Clinical Expert Consensus Document on Standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37:1478-1492.
9. Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation. 2001;103:604-616.
10. Alkan-Onyuksel H, Demos SM, Lanza GM, et al. Development of inherently echogenic liposomes as an ultrasonic contrast agent. J Pharm Sci. 1996;85: 486-490.
11. Demos SM, Alkan-Onyuksel H, Kane BJ, et al. In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. J Am Coll Cardiol. 1999;33:867-875.
12. Hamilton A, Huang SL, Warnick D, et al. Left ventricular thrombus enhancement after intravenous injection of echogenic immunoliposomes: studies in a new experimental model. Circulation. 2002;105:2772-2778.
13. Hamilton AJ, Huang SL, Warnick D, et al. Intravascular ultrasound molecular imaging of atheroma components in vivo. J Am Coll Cardiol. 2004;43:453-460.
14. Buchanan KD, Huang S, Kim H, et al. Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature. J Pharm Sci. 2008;97:2242-2249.
15. Huang SL, Hamilton AJ, Nagaraj A, et al. Improving ultrasound reflectivity and stability of echogenic liposomal dispersions for use as targeted ultrasound contrast agents. J Pharm Sci. 2001;90:1917-1926.
16. Goldstein D, Lewis C. Advances in drug delivery and targeting. Curr Opin Oncol. 1991;3:1096-1104.
17. Kikuchi H, Suzuki N, Ebihara K, et al. Gene delivery using liposome technology. J Control Release. 1999;62:269-277.
18. Tiukinhoy SD, Khan AA, Huang S, et al. Novel echogenic drug-immunoli-posomes for drug delivery. Invest Radiol. 2004;39:104-110.
19. Tiukinhoy-Laing SD, Buchanan K, Parikh D, et al. Fibrin targeting of tissue plasminogen activator-loaded echogenic liposomes. J Drug Target. 2007;15: 109-114.
20. Kim H, Laing ST, Kee P, et al. In vivo enhancement of adventitial neovas-cularization in developing atheroma using targeted echogenic immunolipo-somes. Circulation. 2007;116:II-241.
21. Klegerman ME, Hamilton AJ, Huang SL, et al. Quantitative immunoblot assay for assessment of liposomal antibody conjugation efficiency. Anal Biochem. 2002;300:46-52.
22. Lasch J, Weissig V, Brandl M. Preparation of liposomes. In: Torchilin VP, Weissig V, eds. Liposomes: A Practical Approach. 2nd ed. New York, NY: Oxford University Press; 2003:24-25.
23. Edgell T, McEvoy F, Webbon P, et al. Monoclonal antibodies to human fibrin: interaction with other animal fibrins. Thromb Haemost. 1996;75:595-599.
24. Smith DA, Porter TM, Martinez J, et al. Destruction thresholds of echogenic liposomes with clinical diagnostic ultrasound. Ultrasound Med Biol. 2007; 33:797-809.
25. Klegerman ME, Huang S, Parikh D, et al. Lipid contribution to the affinity of antigen association with specific antibodies conjugated to liposomes. Biochim Biophys Acta. 2007;1768:1703-1716.
26. Prati F, Arbustini E, Labellarte A, et al. Eccentric atherosclerotic plaques with positive remodelling have a pericardial distribution: a permissive role of epicardial fat? A three-dimensional intravascular ultrasound study of left anterior descending artery lesions. Eur Heart J. 2003;24:329-336.
27. Sanz-Requena R, Moratal D, Garcia-Sanchez DR, et al. Automatic segmentation and 3D reconstruction of intravascular ultrasound images for a fast preliminary evaluation of vessel pathologies. Comput Med Imaging Graph. 2007;31:71-80.
28. Kohchi K, Takebayashi S, Hiroki T, et al. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. Circulation. 1985;71:709-716.
29. Moreno PR, Purushothaman KR, Fuster V, et al. Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation. 2002;105:2504-2511.
30. Dobrin PB. Effect of histologic preparation on the cross-sectional area of arterial rings. J Surg Res. 1996;61:413-415.
31. Falk E. Coronary artery narrowing without irreversible myocardial damage or development of collaterals. Assessment of "critical" stenosis in a human model. Br Heart J. 1982;48:265-271.
32. LeVeen RF, Wolf GL, Turco MA. Morphometric changes in normal arteries and those undergoing transluminal angioplasty. Invest Radiol. 1983;18:63-67.
33. Loraine Lowder M, Li S, Carnell PH, et al. Correction of distortion of histologic sections of arteries. J Biomech. 2007;40:445-450.
34. Demos SM, Dagar S, Klegerman M, et al. In vitro targeting of acoustically reflective immunoliposomes to fibrin under various flow conditions. J Drug Target. 1998;5:507-518.